Price loading...

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications
Format
paperback
ASIN
B00E4DC8UO
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
98% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

£325.00 08 Jan 2026
The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East
97% match

The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East

£325.00 25 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Europe
96% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

£425.00 25 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East
96% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East

£425.00 14 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean
96% match

The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean

£425.00 14 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Asia
96% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

£425.00 23 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana
95% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana

£425.00 21 Mar 2026
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
95% match

The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East

£325.00 20 Apr 2026
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Middle East
95% match

The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Middle East

£325.00 07 Jan 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America
95% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

£425.00 24 Jan 2026
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe
95% match

The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe

£325.00 13 Jan 2026
The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Europe
95% match

The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Europe

£325.00 26 Jan 2026
The 2013-2018 Outlook for Neurostimulation Devices in The Middle East
95% match

The 2013-2018 Outlook for Neurostimulation Devices in The Middle East

£325.00 08 Jan 2026
The 2013-2018 Outlook for Systemic Analgesic Medications in India
95% match

The 2013-2018 Outlook for Systemic Analgesic Medications in India

£495.00 12 Jan 2026
The 2013-2018 Outlook for Anticoagulants in Europe
95% match

The 2013-2018 Outlook for Anticoagulants in Europe

£325.00 22 Jan 2026
The 2013-2018 Outlook for Anticoagulants in Africa & the Middle East
95% match

The 2013-2018 Outlook for Anticoagulants in Africa & the Middle East

£325.00 24 Jan 2026
The 2013-2018 Outlook for Allergy Drugs in Africa, Europe & the Middle East
95% match

The 2013-2018 Outlook for Allergy Drugs in Africa, Europe & the Middle East

£325.00 12 Jan 2026
The 2013-2018 Outlook for Anesthesia Disposables in The Middle East
95% match

The 2013-2018 Outlook for Anesthesia Disposables in The Middle East

£325.00 31 Jan 2026
The 2013-2018 Outlook for Drugs in India
95% match

The 2013-2018 Outlook for Drugs in India

£495.00 16 Dec 2025
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
95% match

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

£595.00 22 Jan 2026
The 2013-2018 Outlook for Medical Oxygen Systems in Europe & the Middle East
95% match

The 2013-2018 Outlook for Medical Oxygen Systems in Europe & the Middle East

£325.00 04 Apr 2026
The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean
95% match

The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2013-2018 Outlook for Chilled Microwavable Foods in Europe & the Middle East
95% match

The 2013-2018 Outlook for Chilled Microwavable Foods in Europe & the Middle East

£325.00 24 Jan 2026
The 2013-2018 Outlook for Herbal Supplements and Remedies in The Middle East
95% match

The 2013-2018 Outlook for Herbal Supplements and Remedies in The Middle East

£325.00 31 Jan 2026